Processing

Please wait...

Settings

Settings

Goto Application

1. WO2009006565 - FORMULATIONS AND METHODS FOR INHIBITING ANAEROBES, GRAM NEGATIVE BACTERIA, PROTOZOA AND OTHER MICROBIAL GROWTH WITH MORINDA CITRIFOLIA L. ENHANCED FORMULATIONS

Publication Number WO/2009/006565
Publication Date 08.01.2009
International Application No. PCT/US2008/069136
International Filing Date 03.07.2008
Chapter 2 Demand Filed 30.03.2009
IPC
A61K 36/746 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
74Rubiaceae (Madder family)
746Morinda
CPC
A01N 65/00
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
65Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
A01N 65/08
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
65Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
08Magnoliopsida [dicotyledons]
A61K 36/746
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
74Rubiaceae (Madder family)
746Morinda
A61K 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Y02A 50/30
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applicants
  • TAHITIAN NONI INTERNATIONAL, INC. [US]/[US] (AllExceptUS)
  • KEHAATI, 'afa Palu [TO]/[US] (UsOnly)
  • WEST, Brett Justin [US]/[US] (UsOnly)
  • JENSEN, Claude Jarakae [US]/[US] (UsOnly)
Inventors
  • KEHAATI, 'afa Palu
  • WEST, Brett Justin
  • JENSEN, Claude Jarakae
Agents
  • KRIEGER, Michael F.
Priority Data
12/167,01102.07.2008US
60/948,02705.07.2007US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) FORMULATIONS AND METHODS FOR INHIBITING ANAEROBES, GRAM NEGATIVE BACTERIA, PROTOZOA AND OTHER MICROBIAL GROWTH WITH MORINDA CITRIFOLIA L. ENHANCED FORMULATIONS
(FR) FORMULATIONS ET PROCÉDÉS D'INHIBITION D'ANAÉROBIES, DE BACTÉRIES À GRAM NÉGATIVES, DE PROTOZOAIRES ET D'AUTRES CROISSANCES MICROBIENNES AVEC DES FORMULATIONS AMÉLIORÉES DE MORINDA CITRIFOLIA L.
Abstract
(EN)
The invention relates to the administration of products enhanced with Morinda citrifolia L. in order to inhibit anaerobes, gram negative bacteria, protozoa and other microbial growth related to various maladies and illnesses which result in detrimental physiological effects.
(FR)
La présente invention concerne l'administration de produits améliorés avec Morinda citrifolia L. Ces produits visent à inhiber les anaérobies, les bactéries à Gram négatives, les protozoaires, ainsi que d'autres croissances microbiennes liées à diverses maladies et pathologies qui entraînent des effets physiologiques néfastes.
Latest bibliographic data on file with the International Bureau